… to 69 years attributable to air pollution, according to research presented in today’s Presidential Symposium Plenary … the amount of air pollution in the country. Berg and co-researcher Dr. Joan Schiller, an adjunct professor at the … of Virginia and a Board Member of the Lung Cancer Research Foundation, sought to better understand the worldwide …

… the treatment of unresectable pleural mesothelioma. But research published today in the  Journal of Thoracic Oncology … Vincent's Hospital, Darlinghurst, Australia, and fellow researchers retrospectively collected demographic and … a multidisciplinary approach and includes original research reviews and opinion pieces. The audience includes …

… Chris Martin CMartin@DavidJamesGroup.com | 630-670-2745 Research Presented at International Association for the Study … for relapsed malignant mesothelioma (MM), according to research presented today at the International Association for … Relapsed Mesothelioma (CONFIRM) study, funded by Cancer Research UK/Stand Up To Cancer. The investigator-led, …

… (San Diego, Calif.--September 7, 2024, 8:30 a.m.) — Research presented today suggests an artificial intelligence … mutation prediction from histopathology slides.   The research was presented today at the IASLC 2024 World … Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease, the First Affiliated …

… the 2025 Mary J. Matthews Pathology/Translational Research Award. She has contributed to the IASLC WCLC for more … Gomez has conducted landmark clinical and translational research in early-stage , locally advanced , and, … therapy. Dr. Najmeh leads the patient outcomes research team within her division and is actively involved in …

… Patient perspectives provide context for research advances discussed at the IASLC 2020 North America … issues, clinical trial participation and design, and research endpoints that are meaningful to the lung cancer community.  The conference will provide research updates in the forms of data presentations given by …

… STK11 ,  KEAP1  or  KRAS  mutational status, according to research from the POSEIDON trial presented at the IASLC World … with  STK11  and/or  KEAP1 . Based on these findings, researchers theorized that the triplet regimen tremelimumab, … ,  STK11  and  KEAP1  mutational status. Dr. Peters and researchers at study locations randomized   1013 patients …

… declined 43% during the COVID-19 pandemic, according to research presented today at the IASLC 2021 World Conference on … suspension of trials (60%), institutional closures (39%), research staff availability (48%), and protocol compliance … (14%),” Dr. Smeltzer said. To respond to these barriers, researchers used several strategies, including: modified …

… community including physicians, nurses, other clinicians, researchers and scientists as well as patients, survivors and … include interactive educational sessions, late-breaking research, live chats with industry and e-poster presenters, … By hosting global conferences, funding cutting-edge research and educating the health care community and the …

… on Lung Cancer highlights the best in lung cancer research. Like the previous two meetings, this conference will … moderated by an IASLC member and include an IASLC Patient Research Advocate, to provide a unique perspective on how research may affect patients coping with lung cancer. Zoom …